Position in OCGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$76,054
+$22,054 QoQ
Shares Held
42,019
+5.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO holds $26,257,718 across 141 Biotechnology names. OCGN ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
49,020 | $5,166,708 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,856 | $3,954,558 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,053 | $3,131,509 | |
| 4 | INCY |
Incyte Corp
|
32,727 | $3,080,265 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,761 | $2,189,608 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
9,815 | $1,855,525 | |
| 7 | RPRX |
Royalty Pharma plc
|
29,981 | $1,438,188 | |
| 8 | MRNA |
Moderna, Inc.
|
19,187 | $974,699 |
All Filings in OCGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,054 | 42,019 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $54,000 | 40,000 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $65,200 | 40,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,800 | 40,001 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $28,240 | 40,000 | Shares | Defined | 2025-05-14 | |
| 2023-09-30 | $200 | 500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $54 | 100 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $85 | 100 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $2,519 | 1,110 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $3,300 | 1,000 | Shares | Defined | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||